European Silent Heart Attack Market to Reach $2.7 Billion by 2035

European silent attack market was valued at $1.4 billion in 2025 and is projected to reach $2.7 billion by 2035, growing at a CAGR of 6.9% from 2026 to 2035. The market is primarily driven by the increasing prevalence of cardiovascular diseases and the growing adoption of advanced diagnostic technologies. According to the World Health Organization, cardiovascular diseases continue to be the leading cause of death worldwide, accounting for approximately 19.8 million casualties each year, with nearly 85% resulting from heart attacks and strokes. Across Europe, these conditions represent a substantial portion of overall mortality, underscoring the importance of early detection and effective management of asymptomatic cases such as silent heart attacks. This rising disease burden is fueling the demand for advanced diagnostic solutions, including electrocardiograms (ECGs), cardiac biomarkers, and remote monitoring devices. Furthermore, improvements in healthcare infrastructure and growing awareness regarding silent cardiac conditions are contributing to the expansion of the market.

Browse the full report description of “European Silent Heart Attack Market Size, Share & Trends Analysis Report by Diagnostic (Electrocardiogram (ECG), Cardiac Biomarkers Testing (Troponin, CK-MB), Cardiac Imaging, Wearable & Remote Monitoring Devices), by Treatment Type (Pharmacological Treatment, Interventional Procedures, Lifestyle & Preventive Management), by End-Use Industry (Hospitals, Cardiology Clinics, Diagnostic Centers, Homecare Settings), and Forecast Period (2026–2035)” at https://www.omrglobal.com/industry-reports/european-silent-heart-attack-market

Competitive Landscape of the European Silent Heart Attack Market

The key players in the European silent heart attack market include top companies such as Abbott Laboratories, Medtronic, Danaher, Siemens Healthineers, and GE HealthCare, among others. The market is experiencing strong growth due to increasing awareness of silent myocardial infarction and advancements in diagnostic technologies such as high-sensitivity troponin tests and AI-enabled imaging systems. Hospitals and diagnostic centers are increasingly adopting continuous cardiac monitoring solutions to improve early detection rates. Moreover, wearable and remote monitoring devices are transforming patient management by enabling real-time tracking and preventive intervention.

• In March 2026, Siemens Healthineers introduced its new Artis family of angiography systems, designed to enhance precision in image-guided therapies using AI-enabled technologies. The platform improves imaging quality and workflow efficiency, supporting minimally invasive cardiovascular procedures and early disease detection.
• In August 2025, Abbott announced that its Navitor transcatheter aortic valve implantation (TAVI) system received CE Mark approval in Europe for expanded use in patients with severe aortic stenosis. The approval extends treatment eligibility to low- and intermediate-risk patients, significantly increasing the number of patients who can benefit from minimally invasive cardiac procedures.

Market Coverage

• The market number available for – 2025–2035
• Base year- 2025
• Forecast period- 2026–2035
• Segment Covered-

• By Diagnostic
• By Treatment Type
• By End User

• Competitive Landscape: Abbott Laboratories, Medtronic, Danaher, Siemens Healthineers, and GE HealthCare, among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

European Silent Heart Attack Market Report Segment

By Diagnostic

• Electrocardiogram (ECG)
• Cardiac Biomarkers Testing (Troponin, CK-MB)
• Cardiac Imaging
• Wearable & Remote Monitoring Devices

By Treatment Type

• Pharmacological Treatment
• Interventional Procedures
• Lifestyle & Preventive Management

By End User

• Hospitals
• Cardiology Clinics
• Diagnostic Centers
• Homecare Settings

European Silent Heart Attack Market Report Segment by Country

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/european-silent-heart-attack-market